Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

DarioHealth to Report Financial Results for the Second Quarter 2020 Results on August 12

DRIO

Earnings Discussion and Business Update Scheduled for 9:00 am Eastern Time

NEW YORK, Aug. 7, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial results on Wednesday, August 12, 2020, and host a conference call at 9:00am Eastern Time.

DarioHealth Logo

The call will be hosted by Erez Raphael, Chief Executive Officer, Rick Anderson, President and General Manager of North America, and Zvi Ben-David, Chief Financial Officer.

Conference Call Details

Date: Wednesday, August 12, 2020
Time: 9:00 am EDT
Toll Free: 844-369-8770
International: 862-298-0840
Conference ID: DarioHealth Second Quarter 2020 Earnings Call and Webcast
Webcast: https://www.webcaster4.com/Webcast/Page/2224/36466

Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through August 26, 2020. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 36466. The webcast replay will be available through November 12, 2020.

About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, please go to: http://mydario.com.

DarioHealth Contact:
Claudia Levi
Content & Communications Manager
claudia@mydario.com
347-767-4220

Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+ 646-627-8390

Cision View original content:http://www.prnewswire.com/news-releases/dariohealth-to-report-financial-results-for-the-second-quarter-2020-results-on-august-12-301108320.html

SOURCE DarioHealth Corp.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today